The results of the OUTBACK trial, a landmark multinational phase 3 trial investigating the efficacy of adjuvant chemotherapy in women with locally advanced cervical cancer, have been published in The Lancet Oncology. The trial aimed [...]
In celebration of their 20 year anniversary, ANZGOG is pleased to share the commemorative publication: ‘20 Years Improving Life for Women Through Cancer Research, Part Two.’ In Part Two of '20 Years Improving Life [...]
In celebration of their 20 year anniversary, ANZGOG is pleased to share the commemorative publication: ‘20 Years Improving Life for Women Through Cancer Research, Part One.’ It is my great pleasure to share this [...]
The SPIRIT-Path guidelines for the inclusion of pathology in clinical trial protocols have been published in The Lancet Oncology. Prof Anna DeFazio, Chair TR-ANZGOG Steering Committee The SPIRIT-Path extension guidelines were developed [...]
A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]
Professor Penny Webb gives insight into the new British Journal of Cancer publication for an ovarian cancer study. The study looked at the use of a statin to improve survival for women with ovarian cancer. [...]
WHAM (What Happens After Menopause?) was a multicentre prospective study investigating the impact of risk reducing bilateral salpingo-oophorectomy on non-cancer outcomes in young high-risk women. The ANZGOG supported study assessed the relationship between surgical menopause and [...]
Assoc Prof Alison Brand AM spoke to Dr Norman Swan - the host of ABC Radio’s program Health Report - commenting on a recent paper in the New England Journal of Medicine about gene sequencing and [...]
ANZGOG Member, Dr Tharani Sivakumaran, comments on the findings of a recent publication of an ovarian cancer study that looks into the impact of chemotherapy dose reductions and dose delays on progression-free survival (PFS) in women [...]
ANZGOG Member, Dr Catherine Shannon, comments on a recent publication of an international ovarian cancer study that she collaborated on. Dr Shannon is Senior Medical Oncologist at Mater Cancer Care Centre, a member of Mater Research's [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
